Biomarkers

The Need for Nonprofit Medical Research

Why isn’t there a drug for Dupuytren already? You might hear that surgeons don’t want a Dupuytren cure because it’s so profitable – but take it from a hand surgeon: if Dupuytren disappeared today, surgeons would be happier than patients: no one will miss Dupuytren. So why isn’t there a drug to slow down or […]

Read more ›
DRG goes to Washington
On: Jul 21, 2019
By: Charles Eaton

On July 10th and 11th, the Dupuytren Research Group went to Washington DC. We visited offices of Congressional representatives and other organizations to raise awareness about the impact of Dupuytren disease and the need for federal funding of Dupuytren research. Right now, there are no federal funds directed specifically for Dupuytren research – not at […]

Read more ›
Dupuytren and Rare Disease Research
On: Jul 1, 2019
By: Charles Eaton

Is Dupuytren disease common or rare? I recently attended the Rare Drug Development Symposium in Philadelphia. Why? Is Dupuytren really a rare disease? Yes and no. Mild Dupuytren is common but very severe Dupuytren is rare – in the same way that cats are common but chimeric cats with crazy colors are rare. What does […]

Read more ›
Ten Things to Know About Dupuytren
On: Mar 26, 2019
By: Charles Eaton

There are many reasons to know about Dupuytren disease. Ten of them are on your hands. When Healthgrades.com wanted to know more about Dupuytren disease, they reached out to the Dupuytren Research Group. See the Healthgrades Dupuytren review Dupuytren’s Contracture: 10 Things Doctors Want You to Know featuring Dupuytren specialists on the Dupuytren Research Group […]

Read more ›
Grants.gov: $0 for Dupuytren Research
On: Feb 8, 2019
By: Charles Eaton

Currently, there are no government grants for Dupuytren research. See for yourself: We’re working to change this. You should, too. If you have an idea you want to work on to help jumpstart government funding for Dupuytren Research, let us know! Charles Eaton MD

Read more ›
Shine a light on Dupuytren?
On: Jan 24, 2019
By: Charles Eaton

Dupuytren biology has a lot of overlap with wound healing biology. One description of Dupuytren is that it’s like the body is trying to heal a wound that isn’t there. I used to worry that any treatment described as “promoting” or “accelerating” wound healing might be exactly the wrong thing to do for Dupuytren or […]

Read more ›
Dupuytren: restoring balance vs. winning the war
On: Jan 10, 2019
By: Charles Eaton

There were a number of responses to the last blog post. Annie Stratton wrote something so insightful I’ve included it with permission at the end of this post. The last post used the analogy of war, the war on Dupuytren. That seemed reasonable for several reasons – the importance of strategy and tactics, the concept of […]

Read more ›
Strategies and Tactics of Dupuytren Treatment: Measurement
On: Jan 8, 2019
By: Charles Eaton

This is the introduction to an upcoming series of discussions on the science behind new potential preventive Dupuytren treatments. The guiding mission of the Dupuytren Research Group is to do what needs to be done to prevent and stop Dupuytren. Our goal is the conquest of Dupuytren. Dupuytren damages hands, but the main effort of the […]

Read more ›
PrecisionFDA Dupuytren Blog
On: Dec 6, 2018
By: Charles Eaton

PrecisionFDA Dupuytren Blog PrecisionFDA https://precision.fda.gov/ is a US Government initiative designed to support cutting-edge genomic research and help researchers collaborate across the globe. As a member of PrecisionFDA, Dupuytren Research Group will use PrecisionFDA cloud hosting to allow authorized researchers around the world to collaborate and analyze data from the International Dupuytren Data Bank (IDDB). Data […]

Read more ›
Did You Know These Dupuytren Facts?
On: Nov 29, 2018
By: Charles Eaton

Did You Know These Dupuytren Facts? Did you know? Today, each child of a parent with Dupuytren has a one in four chance of developing Dupuytren. Did you know? Today, there’s no practical way to test if a treatment can prevent Dupuytren. Did you know? Today’s approach to Dupuytren treatment is the same as it was in the 1800s: wait for a bend, […]

Read more ›